Vitreo, a company that manages investment funds has recently brought a new fund to the market, which creates a great opportunity for investors. Vitreo's two cannabis funds aim to help bring some funding to the Brazilian cannabis market. Cannabis consumption is not yet legalized in Brazil as it is in the United States, however, the country is looking like a solid investment opportunity.
Vitreo cannabis funds are a great opportunity to diversify an investment portfolio.
For more information on cannabis in Brazil and other countries from Europe and America, check out the Hemp.im app. This app collects the latest cannabis investing news in bite-sized chunks that are easy to digest.
You can easily find news on how to make money in the burgeoning cannabis industry and other information about cannabis businesses.
The cannabis market is one of the fastest-growing in the world and has everything it needs to expand even further.
Compared to other drugs, cannabis has the biggest chance to be legalized in a good part of the world. It is a fact that cannabis has been slowly released around the world and has been gaining the sympathy of the public and the market.
Vitreo cannabis funds are aimed at qualified investors. For example, it is for those with more than a million dollars. As such, the initial investment amount is $1,000 (R$5,000).
Vitreo has launched its Cannabidiol Light fund that addresses all investors. This fund is particularly intended for small investors.
The problem is that both funds continue with the initial investment value of $1,000 (R$5,000), which is considered a restrictive amount by some.
When you offer an investment opportunity for everyone, by placing an initial investment value of $1,000 (R$5,000) you end up restricting the investment again.
Additionally, the cannabis market, no matter how much it is growing, is not yet consolidated in the world. It is growing, but it can also suddenly collapse, and that can affect all investors.
Some analysts believe that the fund should be launched in the market with an initial value of $235 (R$1,000). That would be something more appealing and would give the possibility to a good part of the people to risk part of their patrimony in something different and innovative.
Even if you have $1,000 (R$ 5,000) to invest in a fund like Cannabidiol Light, you need to analyze your portfolio. Only then, you will be able to identify if you are putting too much money into the Vitreo cannabis fund.
An investor who has a portfolio of $7,000 (R$ 30,000) for example, cannot leave part of the equity allocated to a risk fund such as Cannabidiol Light. Even with 80% of the investor fund, Cannabidiol Light still has its risks.
It is worth noting that Empiricus and Vitreo have a partnership. While the Vitreo Cannabidiol Light Fund value is too high, it is worth considering other funds like “Best Funds.”
The FOF Best Funds is worth mentioning because the fund has been showing good profitability. Within its management, the fund takes into account the strategy developed by Empiricus itself.
In other words, that fund can serve as a kind of benchmark for the investor. The FOF Best Funds is already a product that delivers results.
Without a doubt, the fund has been offering its shareholders excellent profitability. The initial investment value is $235 (R$1,000). Of course, there are some other more accessible funds that offer the possibility of investing from $23 (R$100) or even $117 (R$500).
__
(Featured image by JESHOOTS.COM via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in JANUSINVESTIMENTOS, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The DEA has postponed a key hearing on the reclassification of cannabis. The hearing was…
A new California Department of Public Health report has come out with recommendations for THC…
Ontario is investing $31 million over the next three years to enhance efforts against illegal…
Frankfurt and Hanover are launching five-year pilot projects for legal, regulated cannabis sales to adults,…
Italy's Regional Administrative Court suspended the Health Ministry's decree labeling CBD as a narcotic, pending…
This November, five U.S. states will vote on measures related to legalizing recreational or medical…